Iqvia

Rediff.com » News » Iqvia

News for Iqvia

News
Business

Bharat Biotech finds Covaxin 81% efficient in Phase 3 trials

Bharat Biotech's vaccine, whose emergency use approval before finishing final stage testing had triggered a row, has shown an 81 per cent efficacy in preventing symptomatic COVID-19 in an interim......

Cipla, Torrent may need to divest 15 brands in buyout deal: Bernstein

As the market buzzes with news of Cipla promoters exiting the business through a stake sale and Ahmedabad-based Mehta family-led Torrent Pharmaceuticals racing to acquire its rival, Cipla, an......

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Image used for......

Smaller towns witness strong growth in sales of medicines

Medicine sales grew at a fast clip in smaller cities like Madurai, Meerut, Agra, and Varanasi in the last 12 months. Illustration: Uttam Ghosh/Rediff.com The domestic pharmaceutical market,......

328 fixed-dose combination drugs banned on safety grounds

The original list had named 349 drugs, but 15 drugs, which include cough and cold medicines Phensedyl and Tixylix, approved prior to 1988, have been kept outside the purview of the ban The health......

Rediff News

Iqvia

News for Iqvia

Bharat Biotech finds Covaxin 81% efficient in Phase 3 trials

Cipla, Torrent may need to divest 15 brands in buyout deal: Bernstein

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Smaller towns witness strong growth in sales of medicines

328 fixed-dose combination drugs banned on safety grounds

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS